Characterization of the Extended-Spectrum beta-Lactamase Producers among Non-Fermenting Gram-Negative Bacteria Isolated from Burnt Patients

Authors

  • Ali Hashemi Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Fatemeh Fallah Pediatric Infections Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Hossein Goudarzi Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Masoumeh Hallajzadeh Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Mojdeh Hakemi Vala Shahid Beheshti University of Medical Sciences
Abstract:

Background & Aims of the Study: Extended-spectrum beta-Lactamases (ESBLs) represent a major group of beta-lactamases which are responsible for resistance to oxyimino-cephalosporins and aztreonam and currently being identified in large numbers throughout the world. The objective of this study was to characterize ESBL producers among non-fermenter gram-negative bacteria isolated from burnt patients. Materials &Methods: During April to July 2012, 75 non-fermenter gram-negative bacilli were isolated from 240 bacterial cultures collected from wounds of burnt patients admitted to the Burn Unit at Shahid Motahari Hospital (Tehran, Iran). Bacterial isolation and identification was done using standard methods. Antimicrobial susceptibility testing was performed by disk diffusion method for all strains against selected antibiotics and minimum inhibitory concentration was determined by microdilution test. The ability to produce ESBL was detected through double disk synergy test among candidate strains. Results: Of 75 non-fermenter isolates, 47 Pseudomonas aeruginosa and 28 Acinetobacter baumannii were identified. The resistance of P. aeruginosa isolates to tested antibiotics in antibiogram test were 100% to cefpodoxime, 82.98% to ceftriaxone, 78.73% to imipenem, 75% to meropenem, 72.72% to gentamicin, 69.23% to ciprofloxacin and aztreonam, 67.57% to cefepime, 65.95% to ceftazidime, and 61.53% to piperacillin. The results for Acinetobacter baumannii were 100% to ceftazidime, cefepime, ciprofloxacin, imipenem, meropenem, cefpodoxime, and cefotaxim, 96.85% to gentamicin, 89.65% to ceftriaxone, 65.51% to aztreonam, and 40% to piperacillin. Double disk synergy test showed that 21 (28%) of non-fermenter isolates were ESBL producer. Conclusions: None of the third or fourth generation of cephalosporins is suitable for treatment of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from burnt patients.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Screening of Extended Spectrum Beta lactamase Producing Gram Negative Bacilli Isolated from Clinical Cases

Abstract Background and objectives: (ESBL) strain is one of the emerging health related problems in the world recently. Some of the species of the gram-negative bacilli including Klebsiella Pneumonia & Escherichia Coli are well known ESBL producing among bacteria, and they cause uncontrollable infections. This Cross-sectional study was designed to asses the ESBL producing gra...

full text

Prevalence of Extended-Spectrum Beta-Lactamase in Gram Negative Bacteria Isolated from Kermanshah Medical Centers: A Systematic Review and Meta-Analysis

Background and Aim: Nosocomial infections caused by gram-negative bacteria are among the most important health-threatening challenges of the current century, particularly following the emergence and spreading of antibiotic-resistance strains. Extended-spectrum beta-lactamase (ESBL), one of the most important antibiotic resistance mechanisms, is spreading worldwide. Surveillance and gathering da...

full text

Molecular Identification of ESBLs Genes (blaTEM, blaSHV and blaCTX) among Non-fermenting Gram-negative Bacteria Isolated from Hospitalized Patients in Mazandaran Province, Iran

Background and purpose: Production of beta-lactamase enzymes by bacteria, especially Extended-spectrum β-lactamases (ESBLs) is one of the major problems worldwide. ESBLs are mostly located on bacterial plasmids and it is recognized that SHV, TEM, and CTX-M are prevailing among them. The aim of this study was to determine the ability to produce ESBLs genes based on molecular method among non-fer...

full text

The effect of silver nanoparticles on Gram-negative bacilli Resistant to Extended-Spectrum Β-Lactamase Enzymes

Abstract: Background and objectives: Antibiotic resistant to Antimicrobial agents is one of the most important concern in hospitals, which can lead to increased costs, treatment fails and mortality rates. The aim of this study was identification of Gram-negative bacilli resistant to extended-spectrum β-lactamase Enzymes (ESBLs) and determination of the effect of silver nanoparticles on the...

full text

Community-acquired urinary tract infections by extended-spectrum beta-lactamase-producing Gram negative bacteria

Antibiotic resistance among uropathogens causing community acquired urinary tract infection (CAUTI) is increasing worldwide. Severity and endemicity persists despite of wide spread availability of drugs. Knowledge of the aetiology and antimicrobial susceptibility patterns of uropathogens is important in order to determine the best empiric treatment option. Extended-spectrum beta-lactamase (ESBL...

full text

Extended-spectrum Beta-lactamase Producing Gram Negative Bacteria in Iran: a Review

BACKGROUND The emergence and spread of extended spectrum β-lactamase (ESBL)-producing Gram- negative bacteria (GNB), particularly in Enterobacteriaceae, Acinetobacter baumannii, and Pseudomonas aeruginosa, have increased all over the world. ESBLs are characterized by their ability to hydrolyze β-lactams, early cephalosporins, oxyimino-thiazolyl cephalosporins, and monobactams, but not cephamyci...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 2  issue 1

pages  1- 6

publication date 2013-09

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023